The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Kristian Pietras

Kristian Pietras

Research team manager

Kristian Pietras

Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets

Author

  • J. Capdevila
  • A. Meeker
  • R. Garcia-Carbonero
  • Kristian Pietras
  • A. Astudillo
  • O. Casanovas
  • A. Scarpa

Summary, in English

Neuroendocrine tumors (NETs) represent a heterogeneous group of diseases with varied natural history and prognosis depending upon the organ of origin and grade of aggressiveness. The most widely used biomarker to determine disease burden and monitor response to treatment is chromogranin A (CgA), but it is far from being the optimal predictive and prognostic biomarker in NETs. Biological understanding and derived treatment options for NETs have changed markedly in recent years. Over the last decade, the genomic landscape of these tumors has been extensively investigated. This has resulted in the discovery of mutations and expression anomalies in genes and pathways such as the PI3K/Akt/mTOR, DAXX/ATRX, and MEN1, which are promising predictive and prognostic biomarkers and future candidates for targeted therapies. Additionally, the study of tumor stroma and environment are one of the most promising fields for discovery of potential new targets and biomarkers.

Department/s

  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
  • Department of Translational Medicine

Publishing year

2014

Language

English

Pages

345-351

Publication/Series

Cancer and Metastasis Reviews

Volume

33

Issue

1

Document type

Journal article review

Publisher

Springer

Topic

  • Cancer and Oncology

Keywords

  • Neuroendocrine tumors
  • Biomarker
  • Chromogranin A

Status

Published

ISBN/ISSN/Other

  • ISSN: 0167-7659